Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension

Published:2013-05 Issue:3 Volume:165 Page:499-505
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Akagi Satoshi,Nakamura Kazufumi,Matsubara Hiromi,Fukushima Kusano Kengo,Kataoka Noriyuki,Oto Takahiro,Miyaji Katsumasa,Miura Aya,Ogawa Aiko,Yoshida Masashi,Ueda-Ishibashi Hatsue,Yutani Chikao,Ito Hiroshi

Funder

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Primary pulmonary hypertension: a vascular biology and translational research “work in progress”;Archer;Circulation,2000

2. Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin);Higenbottam;Lancet,1984

3. Three-dimensional structure of pulmonary capillary vessels in patients with pulmonary hypertension;Miura;Circulation,2010

4. Primary pulmonary hypertension;Runo;Lancet,2003

5. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits;Yuan;Circulation,2005

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis;2023-12-07

2. Molecular regulation and therapeutic implications of cell death in pulmonary hypertension;Cell Death Discovery;2023-07-12

3. Integrated Analysis of Transcriptome and Metabolome Reveals Distinct Responses of Pelteobagrus fulvidraco against Aeromonas veronii Infection at Invaded and Recovering Stage;International Journal of Molecular Sciences;2022-09-04

4. Vascular Metabolic Mechanisms of Pulmonary Hypertension;Current Medical Science;2020-06

5. A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension;Nature Communications;2019-11-15